Pharmacological Targeting of the Epidermal Barrier

被引:5
作者
Kemeny, Lajos [1 ,2 ]
Nagy, Nikoletta [2 ,3 ]
Csoma, Zsanett [2 ]
Szabo, Kornelia [1 ]
Eros, Gabor [2 ]
机构
[1] MTA SZTE Dermatol Res Grp, Szeged, Hungary
[2] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary
[3] Univ Szeged, Dept Med Genet, Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
Cutaneous barrier; barrier development; barrier impairment; barrier repair; RECESSIVE CONGENITAL ICHTHYOSIS; ATOPIC-DERMATITIS PATIENTS; TRANSDERMAL DRUG-DELIVERY; SKIN BARRIER; TIGHT JUNCTIONS; HYALURONIC-ACID; GENE-MUTATIONS; FILAGGRIN; GLYCEROL; IDENTIFICATION;
D O I
10.2174/1381612822666160726094947
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most important function of the skin is to form a barrier between the body and the external environment. The epidermal barrier prevents transepidermal water loss from the skin, but also serves as a barrier to the entry of harmful environmental allergic, toxic or infectious substances. Inherited defects in the genes encoding the components of the epidermal barrier result in the development of rare genetic disorders, whereas polymorphisms in these genes together with environmental factors cause frequent inflammatory skin diseases, such as atopic dermatitis. In this review, components of the skin-barrier function will be reviewed with special emphasis on how the altered epidermal barrier might be repaired. The different strategies to increase the transdermal penetration of drugs is also discussed.
引用
收藏
页码:5373 / 5381
页数:9
相关论文
共 117 条
[1]   ABCA12 Mutations and Autosomal Recessive Congenital Ichthyosis: A Review of Genotype/Phenotype Correlations and of Pathogenetic Concepts [J].
Akiyama, Masashi .
HUMAN MUTATION, 2010, 31 (10) :1090-1096
[2]   Ichthyosis, Follicular Atrophoderma, and Hypotrichosis Caused by Mutations in ST14 Is Associated with Impaired Profilaggrin Processing [J].
Alef, Thomas ;
Torres, Serena ;
Hausser, Ingrid ;
Metze, Dieter ;
Tuersen, Uemit ;
Lestringant, Gilles G. ;
Hennies, Hans Christian .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (04) :862-869
[3]   Laser-assisted drug delivery in dermatology: from animal models to clinical practice [J].
Ali, Faisal R. ;
Al-Niaimi, Firas .
LASERS IN MEDICAL SCIENCE, 2016, 31 (02) :373-381
[4]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[5]   Are the new moisturizers more effective? [J].
Anderson, P. Chris ;
Dinulos, James G. .
CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) :486-490
[6]   Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[7]   Ultrasound mediated transdermal drug delivery [J].
Azagury, Aharon ;
Khoury, Luai ;
Enden, Giora ;
Kost, Joseph .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 72 :127-143
[8]   Strong irritants masquerading as skin allergens: the case of benzalkonium chloride [J].
Basketter, DA ;
Marriott, M ;
Gilmour, NJ ;
White, IR .
CONTACT DERMATITIS, 2004, 50 (04) :213-217
[9]  
BASLER E, 1992, AM J HUM GENET, V50, P483
[10]  
BATT MD, 1988, J SOC COSMET CHEM, V39, P367